Akero Therapeutics Newsroom

H.C. Wainwright Maintains Akero Therapeutics(AKRO.US) With Buy Rating, Maintains Target Price $50

Moomoo NewsSep 16 11:31 ET

Morgan Stanley Maintains Akero Therapeutics(AKRO.US) With Buy Rating, Maintains Target Price $46

Moomoo NewsSep 10 06:31 ET

Akero Therapeutics' Promising Phase 3 Programs Bolster Buy Rating

TipRanksSep 10 06:03 ET

Morgan Stanley Maintains Akero Therapeutics(AKRO.US) With Buy Rating, Maintains Target Price $46

Moomoo NewsAug 13 08:31 ET

Akero Therapeutics (AKRO) Receives a Buy From Morgan Stanley

TipRanksAug 13 08:19 ET

Akero Therapeutics (AKRO) Gets a Buy From Evercore ISI

TipRanksAug 12 08:52 ET

Akero Therapeutics Analyst Ratings

BenzingaAug 12 07:13 ET

Analysts Offer Insights on Healthcare Companies: AnaptysBio (ANAB), Charles River Labs (CRL) and Akero Therapeutics (AKRO)

TipRanksAug 12 06:37 ET

Buy Rating Affirmed on Akero Therapeutics Amid Promising EFX Trials and Robust Financial Outlook

TipRanksAug 12 06:33 ET

Buy Rating for Akero Therapeutics Backed by Strong Financials and Promising Trial Outcomes

TipRanksAug 9 12:27 ET

Akero Therapeutics Analyst Ratings

BenzingaJun 20 13:21 ET

Akero Therapeutics Analyst Ratings

BenzingaJun 11 14:42 ET

Wolfe Research Initiates Coverage on Akero Therapeutics With Outperform Rating, $40 Price Target

MT NewswiresJun 11 07:15 ET

Akero Therapeutics Analyst Ratings

BenzingaJun 11 06:41 ET

Akero Therapeutics Analyst Ratings

BenzingaMay 15 09:18 ET

Evercore ISI Group Maintains Outperform on Akero Therapeutics, Lowers Price Target to $38

BenzingaMay 15 09:18 ET

Analysts Offer Insights on Healthcare Companies: Avadel Pharmaceuticals (AVDL), Akero Therapeutics (AKRO) and Madrigal Pharmaceuticals (MDGL)

TipRanksMay 13 08:10 ET

Akero Therapeutics Analyst Ratings

BenzingaMay 13 06:44 ET

Positive Buy Rating for Akero Therapeutics Backed by Clinical and Operational Progress

TipRanksMay 13 06:40 ET

Akero Therapeutics Analyst Ratings

BenzingaApr 22 06:22 ET